López-Cortés Georgina I, Palacios-Pérez Miryam, Veledíaz Hannya F, Hernández-Aguilar Margarita, López-Hernández Gerardo R, Zamudio Gabriel S, José Marco V
Theoretical Biology Group, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Network of Researchers on the Chemical Evolution of Life, NoRCEL, Leeds LS7 3RB, UK.
Vaccines (Basel). 2022 May 28;10(6):864. doi: 10.3390/vaccines10060864.
The global scale of the COVID-19 pandemic has demonstrated the evolution of SARS-CoV-2 and the clues of adaptation. After two years and two months since the declaration of the pandemic, several variants have emerged and become fixed in the human population thanks to extrinsic selective pressures but also to the inherent mutational capacity of the virus. Here, we applied a neutral substitution evolution test to the spike (S) protein of Omicron's protein and compared it to the others' variant of concern (VOC) neutral evolution. We carried out comparisons among the interactions between the S proteins from the VOCs (Alpha, Beta, Gamma, Delta and Omicron) and the receptor ACE2. The shared amino acids among all the ACE2 binding S proteins remain constant, indicating that these amino acids are essential for the accurate binding to the receptor. The complexes of the RBD for every variant with the receptor were used to identify the amino acids involved in the protein-protein interaction (PPI). The RBD of Omicron establishes 82 contacts, compared to the 74 of the Wuhan original viral protein. Hence, the mean number of contacts per residue is higher, making the contact thermodynamically more stable. The RBDs of the VOCs are similar in sequence and structure; however, Omicron's RBD presents the largest deviation from the structure by 1.11 Å RMSD, caused by a set of mutations near the glycosylation N343. The chemical properties and structure near the glycosylation N343 of the Omicron S protein are different from the original protein, which provoke reduced recognition by the neutralizing antibodies. Our results hint that selective pressures are induced by mass vaccination throughout the world and by the persistence of recurrent infections in immunosuppressed individuals, who did not eliminate the infection and ended up facilitating the selection of viruses whose characteristics are different from the previous VOCs, less pathogenic but with higher transmissibility.
新冠疫情的全球规模展现了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的演变及适应性线索。自疫情宣布以来的两年零两个月里,由于外在选择压力以及病毒固有的突变能力,出现了多个变体并在人群中固定下来。在此,我们对奥密克戎毒株的刺突(S)蛋白进行了中性替代进化测试,并将其与其他关注变体(VOC)的中性进化进行比较。我们对VOCs(阿尔法、贝塔、伽马、德尔塔和奥密克戎)的S蛋白与受体血管紧张素转换酶2(ACE2)之间的相互作用进行了比较。所有与ACE2结合的S蛋白中的共有氨基酸保持不变,这表明这些氨基酸对于与受体的精确结合至关重要。利用每个变体的受体结合域(RBD)与受体的复合物来确定参与蛋白质-蛋白质相互作用(PPI)的氨基酸。奥密克戎的RBD形成82个接触点,而武汉原始病毒蛋白为74个。因此,每个残基的平均接触点数更高,使得接触在热力学上更稳定。VOCs的RBD在序列和结构上相似;然而,奥密克戎的RBD与结构的偏差最大,均方根偏差(RMSD)为1.11埃,这是由糖基化位点N343附近的一组突变引起的。奥密克戎S蛋白糖基化位点N343附近的化学性质和结构与原始蛋白不同,这导致其被中和抗体识别的能力降低。我们的结果表明,全球大规模疫苗接种以及免疫抑制个体中反复感染的持续存在引发了选择压力,这些个体未能清除感染,最终促成了具有不同于先前VOCs特征的病毒的选择,这些病毒致病性较低但传播性更高。